等待開盤 10-24 09:30:00 美东时间
+0.170
+4.23%
NuCana presented data at ESMO 2025 showing NUC-7738 enhances PD-1 inhibitors' effectiveness in patient-derived organoids from renal cell carcinoma, increasing tumor cell death. This combination targets tumor microenvironment aspects, offering potential benefits for anti-PD-1 refractory cancers. The study supports NUC-7738's mechanism, safety, and efficacy seen in NuTide:701 clinical results, including tumor reduction and prolonged survival in PD-...
10-18 12:00
NUC-3373, a thymidylate synthase inhibitor, combined with pembrolizumab, shows promising efficacy and safety in heavily pre-treated patients with advanced solid tumors. A patient with bladder urothelial carcinoma experienced a 100% reduction in tumor lesion size, while a melanoma patient achieved an 81% reduction in target lesions and remains progression-free at 23 months. Preclinical data support NUC-3373's immunogenic effects, including DAMP re...
10-14 12:00
U.S. stock futures were slightly higher this morning, with the Dow futures gain...
10-08 20:01
Achieve Life Sciences (NASDAQ:ACHV) promoted Craig Donnelly to COO. Mr. Donnelly will lead the supply chain and manufacturing activities with the commercial strategy ahead of a product launch in mid-l...
09-18 23:46
U.S. stocks were mixed, with the Dow Jones index falling more than 100 points o...
09-12 22:24
NuCana (NASDAQ:NCNA) on Friday said it has received formal notification from Nasdaq, confirming that the company is in compliance with all applicable continued listing criteria, including the $1.00 mi...
09-05 21:14
NuCana plc has confirmed compliance with Nasdaq listing criteria, resolving its previous delisting concerns. The company’s cash resources are sufficient to fund operations through 2029, supporting key milestones and upcoming data readouts. NuCana utilizes its ProTide technology to enhance chemotherapy agents, focusing on improving cancer treatment outcomes. Its pipeline includes NUC-7738 and NUC-3373, currently in Phase 2 and Phase 1b/2 studies, ...
09-05 12:00
NuCana shares are trading higher after the company reported a year-over-year in...
08-21 20:17
Bullish上市首周飙升87.9%,手握2.4万枚比特币;大麻股Tilray周涨超58.8%,特朗普拟将大麻改为低危药物;CoreWeave周内暴跌22%,Q2积压订单和支出拖后腿>>
08-16 10:00
Nucana ( ($NCNA) ) just unveiled an announcement. On August 1, 2025, NuCana ann...
08-02 04:56